News

MaxWell Biosystems Launches Commercial Expansion: Strengthening Regional Presence in EMEA

Zurich, Switzerland – May 22, 2025 MaxWell Biosystems AG is advancing its global go-to-market strategy with the establishment of a dedicated EMEA regional team, expanding its presence and partnerships across Europe, the Middle East, and Africa. This move is part of the company’s global commercial evolution as demand continues to rise for its high-resolution electrophysiology platforms. The newly formed EMEA regional team unites sales, business development, account management, and customer success roles to accelerate adoption, strengthen collaborations, and better serve the evolving…

Read More

AxonTracking Assay Competition

Track your Axon to WIN! The Deadline for entries has been extended to Wednesday 12th October. Do you have a cool image of a tracked neuron using our AxonTracking Assay? Share your image and you could win a $2000 Travel Grant to SfN 2022 in San Diego this November! How to Participate: Send an email to info@mxwbio.com with the subject: AxonTracking Assay Competition Attach the image or link and share a short description of the experiment (max. 100 words)  Good…

Read More

MaxWell Biosystems Around the World

Travel Blog | Summer 2022 We caught up with some of our MaxWellers that have been busy representing MaxWell Biosystems around the world at lots of conferences such as ISSCR, FENS, CAN and lots more in between. After some rest we wanted to know all about their life while traveling and any hints and tips they might have to share.   Here is what they had to say!     That’s all for now! Let us know if you enjoyed…

Read More

HyVIS project

MaxWell Biosystems Becomes a Key Partner in a €3M EU-Financed Project “HyVIS”: Next Generation Prosthesis for Visual Restoration Hybrid Synapse for Vision (HyVIS) is a project funded by European Union Horizon 2020 FET-OPEN program 1, which aims to combine several technologies to achieve the groundbreaking restoration of synaptic light-mediated input in retinas with impaired photoreceptors, leading to treatments for diseases such as in retinitis pigmentosa and age-related macular degeneration (AMD). The key focus of HyVIS project is the development of an artificial light-sensitive prosthesis,…

Read More

Look back: the first In-vitro 2D and 3D Neuronal Networks Summit (MaxWell Biosystems User Meeting) 

On April 22nd and 23rd, we hosted the first In-vitro 2D and 3D neuronal Networks Summit (MaxWell Biosystems User Meeting) and were very excited about the tremendously successful outcome, with over 700 registrants from 49 countries!   First Day: Scientific Talks and Discussions Open for All The first day of the meeting was open to everybody. We had very interesting talks from seven invited speakers, who spoke about their work involving iPSC-derived neurons, brain organoids, and also high-density microelectrode array (HD-MEA)…

Read More
Contact Us






Albisriederstrasse 253
8047 Zurich, Switzerland
+41 44 244 24 24
Schedule a call
info@mxwbio.com
Subscribe to our Newsletter